AllianceBernstein Portfolio holdings
AllianceBernstein (AB), formed in 2000 through the merger of Alliance Capital and Bernstein, is a global asset management firm headquartered in Nashville, Tennessee, managing over $759 billion in assets as of late 2024 for institutional investors, financial advisors, and individuals. Known for its research-driven approach, AB offers a diverse range of investment strategies, including equities, fixed income, alternatives, and multi-asset solutions, with a strong emphasis on active management and ESG (environmental, social, governance) integration. The firm, which relocated its headquarters from New York City to Nashville in 2021, operates globally with significant operations in New York, London, and Asia, leveraging its Bernstein Research arm for deep market insights. With a workforce of over 4,700 and a partnership structure led by CEO Seth Bernstein, AB combines a legacy of rigorous analysis with a modern focus on sustainable investing and client outcomes.
Top Buys
| 1 |
Amazon
AMZN
|
+$1.31B |
| 2 |
Nike
NKE
|
+$470M |
| 3 |
Visa
V
|
+$470M |
| 4 |
Etsy
ETSY
|
+$346M |
| 5 |
Gen Digital
GEN
|
+$257M |
Top Sells
| 1 |
Regeneron Pharmaceuticals
REGN
|
+$669M |
| 2 |
Alphabet (Google) Class C
GOOG
|
+$517M |
| 3 |
Procter & Gamble
PG
|
+$388M |
| 4 |
IQVIA
IQV
|
+$299M |
| 5 |
Vertex Pharmaceuticals
VRTX
|
+$298M |
Sector Composition
| 1 | Technology | 23.26% |
| 2 | Healthcare | 14.4% |
| 3 | Consumer Discretionary | 13.9% |
| 4 | Financials | 12.83% |
| 5 | Communication Services | 9.87% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
2876
Phathom Pharmaceuticals
PHAT
$882M
| $416K | ﹤0.01% |
12,300
+1,800
| +17% | +$60.9K |
|
2877
Seneca Foods Class A
SENEA
$765M
| $416K | ﹤0.01% |
8,150
-100
| -1% | -$5.1K |
|
2878
Harmony Biosciences
HRMY
$1.96B
| $415K | ﹤0.01% |
+14,700
| New | +$415K |
|
2879
Weis Markets
WMK
$1.76B
| $415K | ﹤0.01% |
8,025
+1,200
| +18% | +$62.1K |
|
|
BDSI
2880
DELISTED
BioDelivery Sciences International, Inc.
BDSI
| $415K | ﹤0.01% |
116,000
+6,000
| +5% | +$21.5K |
|
2881
Universal Electronics
UEIC
$64M
| $414K | ﹤0.01% |
8,540
-2,260
| -21% | -$110K |
|
|
AWH
2882
DELISTED
Aspira Women's Health Inc. Common Stock
AWH
| $413K | ﹤0.01% |
4,900
+547
| +13% | +$46.1K |
|
2883
Green Brick Partners
GRBK
$3.26B
| $412K | ﹤0.01% |
+18,100
| New | +$412K |
|
2884
Cytosorbents Corp
CTSO
$62.6M
| $411K | ﹤0.01% |
54,500
+2,200
| +4% | +$16.6K |
|
2885
Inseego
INSG
$196M
| $410K | ﹤0.01% |
4,065
-2,367
| -37% | -$239K |
|
2886
iShares S&P Mid-Cap 400 Growth ETF
IJK
$9.14B
| $409K | ﹤0.01% |
5,050
+219
| +5% | +$17.7K |
|
2887
Anterix
ATEX
$413M
| $408K | ﹤0.01% |
6,800
-61,884
| -90% | -$3.71M |
|
|
BFS
2888
Saul Centers
BFS
$794M
| $402K | ﹤0.01% |
8,847
-700
| -7% | -$31.8K |
|
2889
Q32 Bio
QTTB
$21.3M
| $402K | ﹤0.01% |
3,072
+644
| +27% | +$84.3K |
|
2890
Utah Medical Products
UTMD
$203M
| $400K | ﹤0.01% |
4,700
+200
| +4% | +$17K |
|
|
FSRX
2891
DELISTED
FinServ Acquisition Corp. II Class A Common Stock
FSRX
| $399K | ﹤0.01% |
+41,000
| New | +$399K |
|
|
BNFT
2892
DELISTED
Benefitfocus, Inc.
BNFT
| $398K | ﹤0.01% |
28,200
+9,000
| +47% | +$127K |
|
2893
iShares TIPS Bond ETF
TIP
$14B
| $397K | ﹤0.01% |
3,099
-385
| -11% | -$49.3K |
|
2894
Arrow Financial
AROW
$484M
| $394K | ﹤0.01% |
11,982
-1,202
| -9% | -$39.5K |
|
2895
BlackBerry
BB
$2.23B
| $394K | ﹤0.01% |
32,238
-16,857
| -34% | -$206K |
|
2896
Korro Bio
KRRO
$309M
| $394K | ﹤0.01% |
792
+96
| +14% | +$47.8K |
|
2897
Verastem
VSTM
$630M
| $394K | ﹤0.01% |
8,075
+5,433
| +206% | +$265K |
|
|
MSP
2898
DELISTED
Datto Holding Corp.
MSP
| $394K | ﹤0.01% |
14,167
+3,132
| +28% | +$87.1K |
|
|
ALX
2899
Alexander's
ALX
$1.2B
| $393K | ﹤0.01% |
1,465
-150
| -9% | -$40.2K |
|
|
MSDA
2900
DELISTED
MSD Acquisition Corp. Class A Ordinary Shares
MSDA
| $393K | ﹤0.01% |
+39,900
| New | +$393K |
|